淼淼Elva

Paper Talk

Sharing research articles, tracking the latest developments

Určitě navštivte web podcastu a podpořte jeho tvůrce: www.xiaoyuzhoufm.com

Autor

淼淼Elva

Kategorie

Science

Web podcastu

www.xiaoyuzhoufm.com

Nejnovější epizoda

17. říj 2026

Kde poslouchat?

Podcasty v aplikaci Replaio Radio Už brzy

Podcasty míří do aplikace už brzy. Nainstaluj si ji teď a jako první uvidíš úplně nový pohled na podcasty

Stáhnout z Google Play Nainstaluj zdarma Android téměř 10 mil. stažení · hodnocení 4,8 iOS už brzy

Epizody

1434-Lipid Rafts and TRPA1 in Pancreatic Cancer 14.08.2026

This study explores how lipid rafts and the TRPA1 cation channel facilitate the aggressive behavior of pancreatic ductal adenocarcinoma (PDAC) . Researchers found that the FGFR2c receptor migrates into these specialized membrane microdomains upon activation, triggering signaling pathways that drive tumor invasion and the epithelial-mesenchymal transition (EMT) . Experimental results demonstrate th...

1433-miR-424(322)~503 Impairs PTEN-Deficiency 14.08.2026

This research article investigates the role of the miR-424(322)~503 cluster in the development of colorectal cancer triggered by PTEN deficiency . Using genetically modified mouse models, researchers discovered that while this microRNA cluster acts as an oncogene in other tissues, it functions as a tumor suppressor in the colon. The study found that mice lacking both PTEN and the microRNA cluster...

1432-RNASEH2C Regulation in Liver Cancer Immunity 14.08.2026

This scientific research paper identifies RNASEH2C as a critical driver of liver cancer progression by suppressing the immune system's ability to recognize and attack tumors. The study reveals that this enzyme increases TRAF3IP1 expression, which in turn inhibits the mTOR pathway and triggers the lysosomal degradation of a protein called RAI14 . Because RAI14 is essential for macrophages to intern...

1431-Intratumoral Microbiota Remodeling and Immunotherapy 14.08.2026

This review explores how intratumoral microbiota —the diverse collection of bacteria, fungi, and viruses living within tumors—shapes the immune microenvironment and impacts the success of cancer immunotherapy . While these microorganisms can boost treatment by activating T cells and signaling pathways like STING, they can also drive therapeutic resistance by fostering immunosuppressive conditions....

1430-Th17-like Cells and M2 Macrophages in Sarcoma 13.08.2026

This research explores the immunological landscape of soft-tissue sarcomas (STSs) , specifically focusing on the role of tertiary lymphoid structures (TLSs) in patient prognosis. By integrating immunohistochemistry with transcriptomic data , the study demonstrates that mature TLSs containing germinal center B cells are strong indicators of favorable clinical outcomes. The authors identify a novel...

1429-Organelle Dynamics in Cancer Cell Pyroptosis 13.08.2026

This review article examines pyroptosis , a form of inflammatory programmed cell death, through the lens of subcellular organelle dynamics and their role in cancer therapy. Beyond traditional molecular pathways, the text highlights how the nucleus, mitochondria, lysosomes, and Golgi apparatus form an integrated network that executes cell death via gasdermin (GSDM) pore formation . The authors synt...

1428-Decoding Neddylation in Malignancies 13.08.2026

This review article explores neddylation , a vital protein modification process that significantly influences cancer development and progression . The authors detail how this enzymatic cascade regulates protein stability, localization, and function , thereby sustaining various cancer hallmarks such as immune evasion, metabolic rewiring, and therapeutic resistance. While typically viewed as oncogen...

1427-TIGIT Blockade Enhances BCMA-CAR-T Efficacy in Myeloma 13.08.2026

This research article examines the role of the TIGIT immune checkpoint in driving resistance and relapse following BCMA-CAR-T therapy in patients with multiple myeloma. By utilizing single-cell RNA sequencing and flow cytometry, the authors demonstrate that high TIGIT expression on T cells correlates with increased tumor burden , poor prognosis, and accelerated T cell exhaustion. While in vitro in...

1426-YTHDF3 Promotes HPV Carcinogenesis 13.08.2026

This research article investigates the oncogenic role of the m6A RNA reader protein YTHDF3 in promoting cervical cancer driven by high-risk human papillomavirus (HPV) . Through multi-omics analysis and gene-editing techniques, the study identifies a novel YTHDF3/STAT3/IRF7 axis that facilitates viral persistence and tumor growth. The authors demonstrate that YTHDF3 stabilizes STAT3 mRNA , which su...

1425-mTORC1-Independent Glycogen Storage in TSC 12.08.2026

This research study identifies a novel mTORC1-independent pathway that explains why TSC2 gene mutations cause more severe liver disease than TSC1 mutations in Tuberous Sclerosis Complex (TSC) patients. While both defects lead to the hyperactivation of the protein mTORC1 , the researchers discovered that a lack of TSC2 creates an abundance of uncomplexed-TSC1 , which triggers a specific chemical ch...

1424-Somatic Kitl Facilitate Meiotic Prophase I 12.08.2026

This scientific article demonstrates that Kitl/Kit signaling between somatic granulosa cells and germ cells is essential for the initiation and progression of meiosis in female mouse embryos. By utilizing conditional knockout models and single-cell RNA sequencing , the researchers found that a lack of Kitl leads to significant defects in homologous synapsis , DNA repair, and crossover formation du...

1423-NRF1 Upregulation via ER Stress Inhibition 12.08.2026

This scientific report identifies the transcription factor NRF1 as a critical defender against metabolic dysfunction-associated steatohepatitis (MASH) . Researchers discovered that NRF1 levels are significantly depleted in patients and mice with liver disease, leading to a failure in clearing damaged proteins and an increase in ER stress . The study demonstrates that docosahexaenoic acid (DHA) , a...

1422-Mechanisms of First-Line Drug Resistance in HCC 12.08.2026

This review paper examine how epigenetic regulation —specifically non-coding RNA, DNA methylation, and histone modification—drives resistance to sorafenib and lenvatinib in liver cancer. Research highlights that hepatocellular carcinoma cells survive targeted therapy by rewiring metabolic pathways , expanding cancer stem cell populations, and evading programmed cell death . The text details how ab...

1421-Hallmarks of Polyglutamine Spinocerebellar Ataxias 12.08.2026

The review article examines the pathogenesis of polyglutamine spinocerebellar ataxias (PolyQ SCAs) , a group of six inherited neurodegenerative disorders caused by CAG repeat mutations . The authors establish a conceptual framework by categorizing the disease mechanisms into eleven molecular hallmarks divided into three distinct stages. Primary hallmarks involve direct consequences of the mutation...

1420-Ferroptosis in Systemic Lupus Erythematosus 11.08.2026

This research article investigates how systemic lupus erythematosus (SLE) leads to impaired female fertility and poor oocyte quality through a specific biological cascade. By utilizing a chronic mouse model, the study demonstrates that systemic inflammation triggers oxidative stress and mitochondrial dysfunction , which eventually results in ferroptosis , an iron-dependent form of cell death. Thes...

1419-EFHD2 Drives DNA Repair in Radioresistant Cancer 11.08.2026

This research identifies a critical regulatory axis involving hsa-let-7b-5p , the protein EFHD2 , and lactate metabolism that drives radioresistance and immune evasion in colorectal cancer . The study demonstrates that EFHD2 facilitates DNA damage repair and promotes an immunosuppressive tumor microenvironment by enhancing lactate production and stabilizing HIF-1α . Specifically, lactylation of EF...

1418-DHA Potentiates Regorafenib and Anti-PD-1 11.08.2026

This research paper explores how KRAS mutations cause resistance to a combination treatment of regorafenib and anti-PD-1 therapy in patients with colorectal cancer liver metastases . The authors identified dihydroartemisinin (DHA) , a common anti-malarial drug, as a powerful agent capable of selectively degrading mutant KRAS proteins through the autophagy-lysosome pathway . Through various preclin...

1417-ZBP1-Driven Macrophage Pyroptosis in Sepsis 11.08.2026

This study investigates how ZBP1-driven macrophage pyroptosis worsens sepsis-induced acute lung injury by damaging the pulmonary epithelium. Through single-cell RNA sequencing of human and mouse samples, researchers identified a specific group of pyroptosis-associated macrophages that expands during severe sepsis. These macrophages interact with the NLRP3 inflammasome to trigger cell death and rel...

1416-Nrf2 Signaling Mechanisms in Acute Ischemic Stroke 11.08.2026

This research examines how the protein Nrf2 protects different types of brain cells during an acute ischemic stroke . By using specialized mouse models, the authors discovered that Nrf2 performs unique, cell-specific roles to prevent brain damage. In neurons , this protein primarily functions to block ferroptosis , a specific form of iron-dependent cell death. Conversely, in astrocytes , it works...

1415-GLI1 Palmitoylation in Sonic Hedgehog Medulloblastoma 10.08.2026

This research identifies a novel biochemical mechanism where S-palmitoylation regulates the stability of the GLI1 protein, a key driver in Sonic Hedgehog medulloblastoma (MBSHH) . The study demonstrates that the acyltransferase ZDHHC13 attaches a lipid group to GLI1, protecting it from degradation and fueling tumor progression. Conversely, the enzyme ABHD17A acts as a deacylase that removes this m...

1414-CD23 Regulation of NKT17 Homeostasis 10.08.2026

This study identifies CD23 as a critical internal regulator that maintains the balance of NKT17 cells by protecting their survival. Researchers discovered that a lack of CD23 selectively reduces the number of these specific immune cells and decreases their IL-17 production , which in turn lowers airway inflammation in asthmatic models. Mechanistically, CD23 supports the IL-7Rα-mTORC2-AKT signaling...

1413-LSD1-GLS2 Drives Subtype-Specific Chemoresistance 10.08.2026

This research identifies lysine-specific demethylase 1 (LSD1) as a pivotal metabolic regulator that dictates how pancreatic cancer cells respond to chemotherapy based on their molecular subtype. The study demonstrates that inhibiting LSD1 sensitizes RSK-subtype cells, which rely on healthy mitochondrial respiration, while paradoxically inducing resistance in KRAS-subtype cells characterized by mit...

1412-IGFBP5+ Endothelial Drives Colorectal Cancer Metastasis 10.08.2026

This research article examines how a specific protein, IGFBP5 , secreted by endothelial cells , facilitates the spread of colorectal cancer to the liver. By analyzing single-cell RNA sequencing data, the authors identified that vascular invasion is driven by a specialized subpopulation of cells that remodel the tumor microenvironment . The study demonstrates that IGFBP5 binds to the ITGB3 receptor...

1411-RelB/ILF2–GM-CSF Loop Sustains Cancer Immunosuppression 10.08.2026

This research study identifies a specific biochemical signaling loop that drives prostate cancer’s ability to evade the immune system. The authors demonstrate that the interaction between two proteins, RelB and ILF2 , stabilizes the expression of GM-CSF , a cytokine that recruits and activates myeloid-derived suppressor cells (MDSCs) . These MDSCs create an immunosuppressive environment by inhibit...

1410-The BMP7-TGM2 Axis in Preeclampsia Pathogenesis 09.08.2026

This research identifies a critical molecular connection between BMP7 deficiency and the development of preeclampsia (PE) , a dangerous hypertensive disorder during pregnancy. Scientists discovered that BMP7 , a growth factor usually abundant in the placenta, is significantly reduced in patients with PE, leading to an abnormal increase in TGM2 protein levels. Under normal conditions, BMP7 promotes...

Poslouchej podcast Paper Talk v Replaio

Rádio a podcasty v jedné aplikaci - zdarma a bez registrace. Nainstaluj si ji ještě dnes a nepropásni premiéru

Stáhnout z Google Play

Replaio není vydavatelem podcastů; názvy pořadů, obálky a audio patří jejich autorům a šíří se přes veřejné RSS kanály